Frank Pasqualone

Director at Enveric Biosciences.

Raised on Enveric Biosciences filings

$5M

of $5M offered across 1 Form D filing

Form D filings: 1
Teammates: 6
Last filing: May 4, 2026

Company

Enveric Biosciences

Biotech · Cambridge, MA

Non-hallucinogenic neuroplasticity drugs for depression

Non-hallucinogenic neuroplasticity drugs for depression

Investors: 4

Investors: 4
Sector: Biotech
HQ: Cambridge, MA

Enveric Biosciences filings

Enveric Biosciences Form D filings
Filed	Security	Sold of offered	Filing
May 4, 2026	Equity	$5M/ $5M	Form D

EquityFiled May 4, 2026Form D
$5M/ $5M

Works with

Also named on Enveric Biosciences filings

Joseph E. TuckerChief Executive Officer, Form D signerForm D signer Sheila DeWittDirector George W. KeglerDirector Kevin M. CoveneyChief Financial Officer Michael D. WebbDirector Michael SchabackerDirector